149 related articles for article (PubMed ID: 34176753)
21. A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale.
Gordon MJ; Duan Z; Zhao H; Nastoupil L; Ferrajoli A; Danilov AV; Giordano SH
Blood Adv; 2023 Jun; 7(11):2632-2642. PubMed ID: 36753602
[TBL] [Abstract][Full Text] [Related]
22. Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability.
Odejide OO; Cronin AM; Earle CC; LaCasce AS; Abel GA
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26438575
[TBL] [Abstract][Full Text] [Related]
23. Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.
Ayers AA; Lyu L; Dance K; Ward KC; Flowers CR; Koff JL; McCullough LE
Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):699-708.e5. PubMed ID: 31494062
[TBL] [Abstract][Full Text] [Related]
24. Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin's lymphoma (United States).
Chen-Hardee S; Chrischilles EA; Voelker MD; Brooks JM; Scott S; Link BK; Delgado D
Cancer Causes Control; 2006 Jun; 17(5):647-54. PubMed ID: 16633911
[TBL] [Abstract][Full Text] [Related]
25. Cancer care spending and use by site of provider-administered chemotherapy in Medicare.
Shooshtari A; Kalidindi Y; Jung J
Am J Manag Care; 2019 Jun; 25(6):296-300. PubMed ID: 31211557
[TBL] [Abstract][Full Text] [Related]
26. Medication Adherence, Health Care Utilization, and Spending Among Privately Insured Adults With Chronic Conditions in the United States, 2010-2016.
Gillespie CW; Morin PE; Tucker JM; Purvis L
Am J Med; 2020 Jun; 133(6):690-704.e19. PubMed ID: 31987798
[TBL] [Abstract][Full Text] [Related]
27. End-of-Life Spending and Healthcare Utilization Among Older Adults with Chronic Obstructive Pulmonary Disease.
Iyer AS; Goodrich CA; Dransfield MT; Alam SS; Brown CJ; Landefeld CS; Bakitas MA; Brown JR
Am J Med; 2020 Jul; 133(7):817-824.e1. PubMed ID: 31883772
[TBL] [Abstract][Full Text] [Related]
28. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
Smith TJ; Hillner BE; Schmitz N; Linch DC; Dreger P; Goldstone AH; Boogaerts MA; Ferrant A; Link H; Zander A; Yanovich S; Kitchin R; Erder MH
J Clin Oncol; 1997 Jan; 15(1):5-10. PubMed ID: 8996118
[TBL] [Abstract][Full Text] [Related]
29. Medicare and patient spending among beneficiaries diagnosed with chronic myelogenous leukemia.
Kenzik KM; Bhatia R; Williams GR; Bhatia S
Cancer; 2019 Aug; 125(15):2570-2578. PubMed ID: 30973642
[TBL] [Abstract][Full Text] [Related]
30. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and Predictors of Palliative Care Utilization among Hospitalized Patients with Diffuse Large B-Cell Lymphoma.
Jackson I; Etuk A; Jackson N
J Palliat Care; 2023 Apr; 38(2):167-174. PubMed ID: 35006019
[No Abstract] [Full Text] [Related]
32. Patient-Centered Medical Home Activities Associated With Low Medicare Spending and Utilization.
Burton RA; Zuckerman S; Haber SG; Keyes V
Ann Fam Med; 2020 Nov; 18(6):503-510. PubMed ID: 33168678
[TBL] [Abstract][Full Text] [Related]
33. Healthcare utilisation in patients with breast cancer or non-Hodgkin lymphoma who experienced febrile neutropenia in the Netherlands: a retrospective matched control study using the PHARMO database.
Issa DE; Gelderblom H; Lugtenburg PJ; van Herk-Sukel MP; Houweling LM; De La Orden M; van der Werf-Langenberg ME; Nortier JW; de Jong FA
Eur J Cancer Care (Engl); 2015 Mar; 24(2):232-41. PubMed ID: 24528512
[TBL] [Abstract][Full Text] [Related]
34. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
[TBL] [Abstract][Full Text] [Related]
35. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
[TBL] [Abstract][Full Text] [Related]
36. Contributions of HIV to Non-Hodgkin Lymphoma Mortality Trends in the United States.
Howlader N; Shiels MS; Mariotto AB; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1289-96. PubMed ID: 27418269
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: nationwide Korean study.
Lee SJ; Suh CW; Lee SI; Kim WS; Lee WS; Kim HJ; Choi CW; Kim JS; Shin HJ;
Korean J Intern Med; 2014 May; 29(3):352-60. PubMed ID: 24851070
[TBL] [Abstract][Full Text] [Related]
38. Utilization of health care services among Medicare beneficiaries who visit federally qualified health centers.
Lavelle TA; Rose AJ; Timbie JW; Setodji CM; Wensky SG; Giuriceo KD; Friedberg MW; Malsberger R; Kahn KL
BMC Health Serv Res; 2018 Jan; 18(1):41. PubMed ID: 29370837
[TBL] [Abstract][Full Text] [Related]
39. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
40. Potentially Preventable Spending Among High-Cost Medicare Patients: Implications for Healthcare Delivery.
Khullar D; Zhang Y; Kaushal R
J Gen Intern Med; 2020 Oct; 35(10):2845-2852. PubMed ID: 32103440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
